Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc.

The aim of this retrospective, multicentre, observational study was to assess the durability, safety, immune recovery and effectiveness on viral suppression of antiretroviral therapy (ART) in a maraviroc (MVC)-based cohort. We collected clinical, demographical, immunological and virological parameters of adult HIV patients who were infected by CCR5-tropic virus and started an ART regimen containing MVC from 2005 to 2012. We created a longitudinal mixed model to assess the change over time of data. We enrolled 126 drug-experienced patients; the median duration of MVC treatment was 25 months. The probability of stopping ART at one year was 13.3%, and at three years was 27.3%. Statistically significant changes were observed for CD4+ cell count increase ( p < 0.001), HIV-RNA decrease ( p < 0.001) and total cholesterol decrease ( p = 0.005). Ninety-four patients (79.7%) had CD4 ≥ 200 cells/mm3 at baseline while nine of them reached this threshold at nine months (7.6%), 17 (13%) after nine months and six (5%) remained below 200 cells/mm3 at the end of the study. Overall, 114 patients (90.5%) achieved an HIV-RNA ≤ 50 cp/ml. A majority of patients maintained CD4 cell counts of ≥ 200 cells/mm3 and achieved an undetectable HIV viral load within three months. MVC-containing regimens are safe and appear to be a feasible therapeutic option for ART.

[Chronic osteomyelitis due to Pseudomonas aeruginosa: treatment with elastomeric infusor in an outpatient setting]. / Osteomielite cronica daPseudomonas aeruginosa:trattamento antibioticodomiciliare con impiegodi elastomero.

Chronic bacterial osteomyelitis requires long-term antibiotic treatment (at least 6-8 weeks). After in-hospital management, patients are usually discharged and treated in outpatient settings. However, when the aetiology is represented by Gram-negative microorganisms, outpatient treatment could be difficult. Beta-lactam administration by means of an elastomeric infusor may represent an attractive approach. We report two cases of osteomyelitis due to Pseudomonas aeruginosa successfully treated with continuous ceftazidime administration via an elastomeric infusor in outpatient settings. In both cases the patients were free from clinical and laboratory signs of osteomyelitis at the end of treatment and after 12 months follow-up.

Etiology of prosthetic joint infections in a tertiary care centre in Italy.

Prosthetic joint infections (PJIs) represent a severe complication in orthopaedics. Coagulase-negative staphylococci (CoNS) and Staphylococcus aureus represent the most frequent cause, but Gram-negatives have also been reported. With a view to describing the aetiology of PJIs diagnosed from January 2005 to September 2007 at S. Corona Hospital in Pietra Ligure, Italy, we conducted retrospective analysis of pathogens isolated from PJIs by means of surgical specimens, needle aspirates or swabs of fistula (3 samples). During the study period 228 PJIs were described and 141 (62%) were microbiologically documented and evaluated. Early and delayed infections represented 45% of episodes, while late infections were observed in 55%. The aetiology was mono-microbial in 84% of cases, and polymicrobial in 16%. CoNS and S. aureus were the most frequently isolated pathogens. In early and delayed infections methicillin resistant CoNS were 30% and 24%, respectively, while in late infections they were 17%. Methicillin-resistant S. aureus was isolated in 13% of early, 22% of delayed and 15% of late infections. Gram-negatives were described in 16% of episodes without differences being found in the three groups. In our report staphylococci represented the most frequent cause of PJIs. Methicillin-resistant strains were more frequently isolated in early and delayed infections, but their frequency in late episodes was not negligible. Polymicrobial infections and Gram-negative infections were also frequent.

[Bacterial infections in HIV patients]. / Infezioni batteriche in pazienti con malattia da HIV.

AIM OF THE STUDY AND METHODS: Retrospective analysis of bacterial infections occurring in 400 admissions of HIV-positive patients in the Infectious Diseases Unit of the Azienda Ospedale Santa Corona, Pietra Ligure (SV), from January 1994 to September 1996. RESULTS: 56 episodes were documented (14% of admissions): 24 (43%) hospital acquired (11 sepsis, 5 pneumonias, 6 urinary-tract infections, 1 infection of a prosthetic device) and 32 (57%) community-acquired (9 sepsis, 13 pneumonias [6 with bacteremia] 9 urinary-tract infections, 1 endocarditis). At time of diagnosis mean absolute CD4-lymphocyte count was 106/cmm (95% Cl 62-150) and mean neutrophil count was 4.690/cmm (95% Cl 3.466-5.914); 11 patients had a central venous catheter, 9 a vesical catheter and 7 severe skin lesions. Methicillin-resistant S. aureus (11/24, 46%) and Pseudomonas (8/24, 33%) were the most frequently isolated pathogens in hospital infections, while the majority of community acquired episodes were due to S. pneumoniae (10/32, 31%). In six episodes (11%) the patient died because of the bacterial infection. CONCLUSIONS: Bacterial infections are quite frequent in this cohort of HIV-infected patients. Methicillin-resistant S. aureus and Pseudomonas represented the major cause of hospital acquired infections, while S. pneumoniae represented the major cause of community acquired episodes.